Embedded Files
Objective
Objective
To perform a comprehensive epidemiological assessment of Cutaneous Squamous Cell Carcinoma (cSCC), with a focus on understanding the incidence among solid organ transplant recipients across multiple geographies.
Gain actionable epidemiological insights to guide strategic planning and research priorities with DelveInsight’s expertise.
Problem Statement
Problem Statement
A US-based pharmaceutical client sought to understand the prevalence and burden of cSCC among solid organ transplant recipients across 15 key countries, including the US, major European countries, and selected countries from the Asia-Pacific (APAC) region.
The client required a detailed, country-specific assessment to support portfolio planning, market strategy, and clinical development initiatives.
Our Methodology
Our Methodology
1. Secondary Assessment
Conducted an extensive literature review using peer-reviewed publications, clinical trial registries, and epidemiological databases.
Extracted country-specific data on organ transplantation and cSCC incidence rates.
2. Primary Assessment
Engaged Key Opinion Leaders (KOLs) in each country to validate findings and provide qualitative insights.
Captured expert perspectives on risk factors, patient management, and regional treatment practices.
3. Data Integration and Analysis
Synthesized secondary and primary data into a comprehensive, country-level epidemiology model.
Calculated the percentage of transplant recipients developing cSCC for each target country.
Results
Results
Country-Specific Insights: Developed an Excel-based epidemiology model detailing solid organ transplant statistics and cSCC incidence by country.
Executive Summary: Provided a PPT summary highlighting key epidemiological trends, patient burden, and comparative analysis across countries.
KOL Perspectives: Incorporated expert insights from each region, offering nuanced understanding of local risk factors and management practices.
Strategic Utility: Delivered actionable intelligence to support market access planning, clinical research prioritization, and commercial strategy development.
DelveInsight’s epidemiology assessment empowered the client with a clear understanding of cSCC burden among transplant recipients, enabling informed decision-making in clinical and commercial planning.
Leverage DelveInsight’s epidemiology expertise to gain precise, country-specific insights for your therapeutic areas. Contact us today to learn how our assessments can inform research, development, and market strategies.
About Us
DelveInsight is a premier market research and consulting firm focused on healthcare, offering high-quality intelligence and analysis to guide strategic decisions. Our expert team, with profound knowledge of life sciences and healthcare, provides tailored research services and insights worldwide. Reach out for reliable, precise, and timely data to maintain a competitive edge.
Contact Us
Kanishk
kkumar@delveinsight.com
Page updated
Google Sites
Report abuse